Patents Assigned to LEANGENE AB, C/O CIT Ekonomiservice AB
  • Publication number: 20080181877
    Abstract: The present invention relates to a method for monitoring/detecting compounds capable to regulate the transcription and/or expression of the forkhead transcription factor Foxc2, which compounds may be useful for the treatment of obesity related diseases and diabetes.
    Type: Application
    Filed: March 22, 2006
    Publication date: July 31, 2008
    Applicant: LEANGENE AB, C/O CIT Ekonomiservice AB
    Inventors: Sven Enerback, Anna Cederberg